POLİFARMA
ESTABLISHED IN 1086
Polifarma established in 1986, in Istanbul.
GLASS SERUM PRODUCTION
Serum production in glass form started.
BAG SERUM PRODUCTION
The first bag serum production was carried out with the investment in the first semi-automation production line in bag form.
POLYPROPYLENE INVESTMENT
Automated production line for PP bag form investment.
CERTIFICATIONS
ISO 9001 (International Quality Systems) and EN ISO 13485 (International Medical Devices Quality Management System) certifications received.
NEW PRODUCTION FACILITY OPENED
Ergene 1 Organized Industrial Zone Facility was opened.
A NEW ERA IN EXPORT
The first export was made to Azerbaijan.
TRIGGER IN INJECTABLES
In the SVP (small volume parenteral solution) group, the first 7 drug licenses in vial form and the first drug license in PP, IV (intravenous) drug group in bag form were obtained.
GMP CERTIFICATE FOR VETERINARY MEDICINES PRODUCTION
GMP (Good Manufacturing Practices) Certificate for Veterinary Medicine Production from the Turkish Ministry of Agriculture and Forestry received.
ASEPTIC AREA PHASE-I INVESTMENT
Aseptic Area Phase-I injectable vial line investment.
“UTILITY MODEL” INVENTION CERTIFICATE
Received a Utility Model invention certificate from the Turkish Patent and Trademark Office for a product containing paracetamol.
R&D CENTER (POLAr-Ge) ESTABLISHED
POL R&D Center was established with the approval of the Turkish Ministry of Industry and Technology.
ASEPTIC AREA PHASE-II INVESTMENT
Aseptic Area Phase-II injectable vial line and lyophilized/injectable vial and ampoule production line investment.
NUTRITION SOLUTION PROCESS INVESTMENT AND PRODUCTION
Emulsion form lipid production (Nutrition Solution) process invesment and 3-chamber parenteral nutrition solutions production
READY-TO-USE INJECTION PROJECT
Started production of ready-to-use injections.
GOLDEN MORTAR AWARD
Received the Golden Mortar award in the non-drug innovation category.
POLIFARMA ACADEMY PROJECT
Polifarma Academy, an internal social education platform started.
LOGISTICS CENTER
New logistics center opened.
BFS LINE INVESTMENT
BFS line investment.
R&D PROJECT MARKET COMPETITION AWARD
Won the first prize in the pharmaceutical category for the most projects developed in the R&D Project Market competition supported by the Turkish Ministry of Trade, TIM, IKMIB, and TÜBİTAK.
PARAMETRIC RELEASE APPROVAL
Parametric release after production approval was received.
SAP PROJECT
Transitioned to the SAP S/4 Hana system in the ERP system.
SAFE PRODUCTION CERTIFICATE
TSE Covid-19 safe production certificate.
EU-GMP APPROVAL
EU-GMP approval (by the Bulgarian Health Authority).
RANKED IN ISO SECOND TOP 500
Ranked in the Istanbul Chamber of Industry (İSO) Second 500 list.
SINOVAC VACCINE FILLING
Carried out the filling of the Covid-19 Sinovac vaccine.
RAMAN SPECTROSCOPY APPROVAL
Approval for the quantitative test method of Raman spectroscopy.
RANKED IN ISO FIRST TOP 500
Ranked in the Istanbul Chamber of Industry (İSO) First 500 list.
IN-LICENCE AGREEMENTS
Signed a licensing agreement with South Korea-based pharmaceutical company Dong-A ST Co. Ltd. for the sales rights of a biosimilar anti-anemic product in Turkiye, Mexico, and Brazil, and an agreement with French pharmaceutical company Laboratoire Aguettant S.A.S for the marketing rights of an antihypertensive product in Turkiye.
R&D 250 LIST
Ranked in the R&D 250 list of companies making the most investment and running the most projects among R&D centers by Turkish Time.
GOLDEN MORTAR AWARD
Golden Mortar Award in the investment category with a high-tech smart aseptic GMP drug production and filling line.
CERTIFICATIONS
Turkish Standards Institute (TSE) ISO 10002:2018 certification.
NEW INVESTMENTS
Lyophilized/injectable vial production line investment and full automation production line investment for multi-chamber parenteral nutrition products.
ACHIEVEMENT ON ANESTHESIA
Produced the domestic anesthesia inhalation product (containing Sevoflurane active ingredient).
IN-LICENCING AGREEMENTS
Signed a licensing agreement with Iceland-based Alvotech hf. for the sales rights of a new generation ophthalmology product in Turkiye.
HEALTH AUTHORITY APPROVALS
Approvals from the Australian health authority TGA and the UK health authority MHRA.
AWARDS
Won awards such as the "Best In-house Training Project of the Year" category for the "Polifarma Street" project at the Golden Pulse Awards, the "Most Innovative Pharmaceutical Company in R&D" award in the healthcare category at the Global Business Outlook Awards, and an incentive award within the scope of the "Earthquake Shield in Industry Project" by the Çorlu Chamber of Commerce and Industry.
R&D 250 LIST
Ranked in the R&D 250 list of companies making the most investment and running the most projects among R&D centers by Turkish Time.
API PRODUCTION FACILITY
GMP (Good Manufacturing Practices) certified API (active pharmaceutical ingredient) production facility was opened.
RANKED IN ISO FIRST TOP 500
Ranked in the Istanbul Chamber of Industry (İSO) First 500 list
R&D 250 LIST
Ranked in the R&D 250 list of companies making the most investment and running the most projects among R&D centers by Turkish Time.
AWARDS
At the OSB Stars Research, which recognizes the most successful companies in various fields within Organized Industrial Zones, Polifarma was awarded in the "Company with the Highest Female Employment" category. Additionally, at the Golden Pulse Awards, our ‘Patifest’ project, which touches the lives of our beloved animal friends, won the "Most Successful Internal Communication of the Year" award.
GOLDEN MORTAR AWARD
Polifarma received the Golden Mortar Award in the R&D category for the "Local Production of an Orphan Drug from Active Ingredient to Finished Product Through Vertical Integration" project.
CRYSTAL MORTAR AWARD
Thanks to projects that emphasize, support, and add value to API synthesis production, Polifarma was honored with the Crystal Mortar Award at the 13th International Pharmaceutical Chemistry Congress.
Among the ISO Top 500
We have risen 33 places to rank 312th.
List of R&D 500
Polifarma has been recognized in Turkish Time’s ‘R&D 500’ list as one of the R&D centers with the highest investments, the largest number of ongoing projects, and the most registered trademarks.
2025 Capital 500 & Fortune 500
Polifarma has been ranked among Türkiye’s largest companies by revenue in the lists compiled by Capital and Fortune magazines.
2025 Stars of Export
According to the ranking by İKMİB, we are among the Top 10 Pharmaceutical Companies with the Highest Exports.
2025 New R&D Center Opened
The new R&D center, built on an area of 11,233 m² in Tekirdağ Ergene, has been opened.
